NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/21/2022
Back to search
Official data from USPTO
AVERA MEDICAL GROUP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AVERA MEDICAL GROUP
ST13
US500000085064195Class
44
Filing
85064195
Registration
4008369
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2025
Trademark type
Word
Nice classes
44
Filing date
06/16/2010
Registration date
08/09/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/21/2022
Last transaction
04/03/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2008-03-00
First use in commerce
2008-03-00
Drawing code
4
Owner type
03
Owner location
Sioux Falls, SD
Examiner
LUDEMAN, JESSICA
Law office
L40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
A. H. (pessoa física)
A. H. (pessoa física)
Representatives
Madelon Lapidus HOLLAND & HART LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
health care serviceshospitalslong term care facilitiesmedical clinicswellness centersmedical clinics; health maintenance organizations and managed health care services organizations
Publications
History of USPTO decisions and trademark events.
30 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/21/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/21/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/21/2021
PUMI
PROOF OF USE INTERIM ACTION ISSUED
12/02/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/07/2021
PUM1
OFFICE ACTION ISSUED POU1
04/21/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/20/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
04/09/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/09/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/14/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/14/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/14/2016
E815
TEAS SECTION 8 & 15 RECEIVED
08/09/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
08/09/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/24/2011
PUBO
PUBLISHED FOR OPPOSITION
05/24/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/19/2011
ALIE
ASSIGNED TO LIE
04/19/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/05/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/10/2011
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/24/2010
GNRT
NON-FINAL ACTION E-MAILED
09/24/2010
CNRT
NON-FINAL ACTION WRITTEN
09/24/2010
DOCK
ASSIGNED TO EXAMINER
09/24/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/21/2010
NWAP
NEW APPLICATION ENTERED
06/19/2010
Continuous trademark protection
Get notified about every new filing that threatens AVERA MEDICAL GROUP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.